{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:46:16Z","timestamp":1777589176943,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.taap.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T01:27:13Z","timestamp":1525483633000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Investigation of belinostat-induced genomic instability by molecular cytogenetic analysis and pathway-focused gene expression profiling"],"prefix":"10.1016","volume":"350","author":[{"given":"S.M.","family":"Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Al-Hamamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.I.","family":"Harisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.05.002_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.04.006","article-title":"Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model","volume":"68","author":"Ahmad","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.taap.2018.05.002_bb0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.imbio.2015.01.008","article-title":"Regulation of TNF-alpha and NF-kappaB activation through the JAK\/STAT signaling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation","volume":"220","author":"Ahmad","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.taap.2018.05.002_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrgentox.2007.04.010","article-title":"The genotoxic and cytotoxic effects of nicotine in the mouse bone marrow","volume":"632","author":"Attia","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0020","first-page":"1","article-title":"Mutagenicity of some topoisomerase II-interactive agents","volume":"16","author":"Attia","year":"2008","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.taap.2018.05.002_bb0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/em.20451","article-title":"Use of centromeric and telomeric DNA probes in in situ hybridization for differentiation of micronuclei induced by lomefloxacin","volume":"50","author":"Attia","year":"2009","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2018.05.002_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mrfmmm.2011.07.012","article-title":"Comparative aneugenicity of doxorubicin and its derivative idarubicin using fluorescence in situ hybridization techniques","volume":"715","author":"Attia","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mrgentox.2005.03.010","article-title":"Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level","volume":"583","author":"Attia","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/mutage\/get063","article-title":"Genotoxic evaluation of chloroacetonitrile in murine marrow cells and effects on DNA damage repair gene expressions","volume":"29","author":"Attia","year":"2014","journal-title":"Mutagenesis"},{"key":"10.1016\/j.taap.2018.05.002_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/mutage\/gev065","article-title":"Dexrazoxane mitigates epirubicin-induced genotoxicity in mice bone marrow cells","volume":"31","author":"Attia","year":"2016","journal-title":"Mutagenesis"},{"key":"10.1016\/j.taap.2018.05.002_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/toxsci\/kfx161","article-title":"Dexrazoxane averts idarubicin-evoked genomic damage by regulating gene expression profiling associated with the DNA damage-signaling pathway in BALB\/c mice","volume":"160","author":"Attia","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.05.002_bb0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2018.05.002_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","article-title":"Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy","volume":"269","author":"Carew","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2018.05.002_bb0065","series-title":"Pharmacology Review(s)","author":"Center for Drug Evaluation and Research","year":"2014"},{"key":"10.1016\/j.taap.2018.05.002_bb0070","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","article-title":"DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology","volume":"20","author":"Cheung-Ong","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.taap.2018.05.002_bb0075","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.taap.2018.05.002_bb0080","first-page":"4645","article-title":"The role of genomic instability in human carcinogenesis","volume":"19","author":"Coleman","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2018.05.002_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2008.06.005","article-title":"Histone deacetylase inhibitors and genomic instability","volume":"274","author":"Eot-Houllier","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2018.05.002_bb0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"Gryder","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.taap.2018.05.002_bb0100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4161\/cc.4.6.1717","article-title":"Mechanisms of selective anticancer action of histone deacetylase inhibitors","volume":"4","author":"Insinga","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.taap.2018.05.002_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1091581809352111","article-title":"Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat","volume":"29","author":"Kerr","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.taap.2018.05.002_bb0110","first-page":"166","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0115","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.juro.2014.11.091","article-title":"Combination treatment of renal cell carcinoma with belinostat and 5-fluorouracil: a role for oxidative stress induced DNA damage and HSP90 regulated thymidine synthase","volume":"193","author":"Kim","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2018.05.002_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4614-0254-1_14","article-title":"Histone deacetylase inhibitor: antineoplastic agent and radiation modulator","volume":"720","author":"Konsoula","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2018.05.002_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-2694-7_5","article-title":"Western blotting: an introduction","volume":"1312","author":"Kurien","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.taap.2018.05.002_bb0130","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"Lee","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2018.05.002_bb0135","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0140","article-title":"Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.05.002_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2018.05.002_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/mutage\/get018","article-title":"The comet assay, DNA damage, DNA repair and cytotoxicity: hedgehogs are not always dead","volume":"28","author":"Lorenzo","year":"2013","journal-title":"Mutagenesis"},{"key":"10.1016\/j.taap.2018.05.002_bb9000","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.05.002_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fgene.2013.00131","article-title":"Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond","volume":"4","author":"Luzhna","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.taap.2018.05.002_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-230X(04)91004-4","article-title":"Histone deacetylase inhibitors","volume":"91","author":"Marks","year":"2004","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2174\/156802610792232079","article-title":"Macrocyclic histone deacetylase inhibitors","volume":"10","author":"Mwakwari","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.taap.2018.05.002_bb0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.molonc.2012.09.004","article-title":"Trials with \u2018epigenetic\u2019 drugs: an update","volume":"6","author":"Nebbioso","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.taap.2018.05.002_bb0175","first-page":"337","article-title":"HDAC inhibitors: a potential new category of anti-tumor agents","volume":"4","author":"Pan","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.taap.2018.05.002_bb0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jat.1607","article-title":"In vivo genotoxicity assessment of nerolidol","volume":"31","author":"Piculo","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2018.05.002_bb0185","first-page":"263","article-title":"HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity","volume":"23","author":"Purrucker","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2018.05.002_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/fon.12.173","article-title":"Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials","volume":"9","author":"Qiu","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.taap.2018.05.002_bb0195","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2217\/fon.15.62","article-title":"Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma","volume":"11","author":"Rashidi","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.taap.2018.05.002_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not be the best histone deacetylase inhibitors--what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.taap.2018.05.002_bb0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc1170","article-title":"Genomic instability\u2014the engine of tumorigenesis?","volume":"3","author":"Sieber","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2018.05.002_bb0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mrrev.2010.04.005","article-title":"Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods","volume":"705","author":"Waters","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2018.05.002_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1667\/RR0811.1","article-title":"Attenuated DNA damage repair by trichostatin A through BRCA1 suppression","volume":"168","author":"Zhang","year":"2007","journal-title":"Radiat. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T13:33:33Z","timestamp":1617716013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18302011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S0041008X18302011"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.002","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of belinostat-induced genomic instability by molecular cytogenetic analysis and pathway-focused gene expression profiling","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}